We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Third-Largest Generic Company Made With $5 Billion Watson-Actavis Deal
Third-Largest Generic Company Made With $5 Billion Watson-Actavis Deal
May 8, 2012
Watson Pharmaceutical’s purchase of Actavis firmly positions it as one of the top generic-drug makers in the world, giving it access to Asian and European markets it didn’t have before.